Table 3.
Correlation between CTCAE clinician-reported symptoms and adapted-REQUITE or PRO-CTCAE® patient-reported symptoms.
| Symptoms | CTCAE vs adapted REQUITE | CTCAE vs PRO-CTCAE® | ||
|---|---|---|---|---|
| Correlation (95% CI) |
P-value | Correlation (95% CI) |
P-value | |
| Performance Status | 0.91 (0.86, 0.94) | <.001 | ||
| Shortness of Breath | 0.79 (0.67, 0.87) | <.001 | 0.82 (0.72, 0.89) | <.001 |
| Fatigue | 0.79 (0.67, 0.87) | <.001 | 0.66 (0.49, 0.78) | <.001 |
| Cough | 0.77 (0.65, 0.85) | <.001 | 0.73 (0.59, 0.83) | <.001 |
| Reduced appetite | 0.72 (0.57, 0.82) | <.001 | 0.63 (0.45, 0.76) | <.001 |
CTCAE, Common Terminology Criteria for Adverse Events; PRO-CTCAE®, Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events; CI, Confidence Interval.